Montréal and New York advise Aeterna Zentaris on shelf registration

April 5, 2017

Client: Aeterna Zentaris Inc.

Our Montréal and New York offices have advised Aeterna Zentaris Inc. on the filing of a new US$50 million shelf registration statement on Form F-3 and the implementation of a US$9 million "at the market" common share offering program on the NASDAQ Capital Market.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health.

The Montréal team was led by Elliot Shapiro, assisted by Melanie Josepovici and Antoine Desroches.  Chris Hilbert, Manny Rivera, James Lacey and Leslie Hung in New York advised on US law matters.